1. Home
  2. AMZE vs KZIA Comparison

AMZE vs KZIA Comparison

Compare AMZE & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMZE
  • KZIA
  • Stock Information
  • Founded
  • AMZE 2019
  • KZIA 1994
  • Country
  • AMZE United States
  • KZIA Australia
  • Employees
  • AMZE N/A
  • KZIA N/A
  • Industry
  • AMZE Beverages (Production/Distribution)
  • KZIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMZE Consumer Staples
  • KZIA Health Care
  • Exchange
  • AMZE Nasdaq
  • KZIA Nasdaq
  • Market Cap
  • AMZE 5.2M
  • KZIA 5.1M
  • IPO Year
  • AMZE 2021
  • KZIA 1999
  • Fundamental
  • Price
  • AMZE $6.87
  • KZIA $10.77
  • Analyst Decision
  • AMZE
  • KZIA Strong Buy
  • Analyst Count
  • AMZE 0
  • KZIA 2
  • Target Price
  • AMZE N/A
  • KZIA $14.00
  • AVG Volume (30 Days)
  • AMZE 139.7K
  • KZIA 692.0K
  • Earning Date
  • AMZE 08-13-2025
  • KZIA 07-22-2025
  • Dividend Yield
  • AMZE N/A
  • KZIA N/A
  • EPS Growth
  • AMZE N/A
  • KZIA N/A
  • EPS
  • AMZE N/A
  • KZIA N/A
  • Revenue
  • AMZE $254,711.00
  • KZIA $1,549,158.00
  • Revenue This Year
  • AMZE N/A
  • KZIA N/A
  • Revenue Next Year
  • AMZE N/A
  • KZIA N/A
  • P/E Ratio
  • AMZE N/A
  • KZIA N/A
  • Revenue Growth
  • AMZE N/A
  • KZIA 248983.08
  • 52 Week Low
  • AMZE $5.78
  • KZIA $2.86
  • 52 Week High
  • AMZE $28.72
  • KZIA $40.75
  • Technical
  • Relative Strength Index (RSI)
  • AMZE N/A
  • KZIA 75.96
  • Support Level
  • AMZE N/A
  • KZIA $5.86
  • Resistance Level
  • AMZE N/A
  • KZIA $12.00
  • Average True Range (ATR)
  • AMZE 0.00
  • KZIA 1.03
  • MACD
  • AMZE 0.00
  • KZIA 0.41
  • Stochastic Oscillator
  • AMZE 0.00
  • KZIA 90.23

About AMZE Amaze Holdings Inc. Common Stock

Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

Share on Social Networks: